HAEMATOLOGICAL MALIGNANCY
Clinical trials for HAEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HAEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HAEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could existing cancer drugs work for more rare tumors?
Disease control Not yet recruitingThis study tests whether two approved drugs, dabrafenib and trametinib, can shrink or control rare cancers that have a specific genetic change called BRAF V600. About 30 adults and children with various rare cancers will receive the drug combination. The goal is to see if these d…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
CLL referral study aims to uncover hidden inequalities in cancer care
Knowledge-focused Not yet recruitingThis study surveys doctors and nurses to see how they decide when to refer patients with chronic lymphocytic leukemia (CLL) to specialists. The goal is to find differences in care across the West Midlands region and suggest ways to make referrals fairer and more consistent. About…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:06 UTC